Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03448588
Other study ID # Liuyanping3
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2018
Est. completion date April 1, 2019

Study information

Verified date May 2018
Source Peking Union Medical College Hospital
Contact Yanping Liu
Phone +861069159088
Email liuyp1227@vip.sina.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

As one of the essential micronutrients, selenium has important biological functions. However, an effective and convenient method for evaluation of selenium nutritional status has not yet been established. Previous literature has disclosed effect of selenium deficiency on inactivating glutathion peroxidase and deiodinase, which may cause decreased conversion from thyroxine ( T4) to triiodothyronine (T3). A case-control study is designed to demonstrate the association between selenium deficiency and abnormally elevated T4 or T4/T3, which may provide more clues for establishing effective selenium assesment methods.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date April 1, 2019
Est. primary completion date December 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- with normal free triiodothyronine( FT3), free thyroxine (FT4) and thyroid-stimulating hormone (TSH).

- without thyroid hormone replacement therapy

- without medical history of thyroid surgery

- without iodine radiotherapy;

Exclusion Criteria:

- acute critical illness in the latest 1 year;

- weight fluctuation by more than 5% in the latest 3 months;

- eating disorders

- neuropsychological disorders

- allergy to corn or yeast

- fail to give informed consents.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
detection of serum selenium
For this case-control study, no intervention will be administered to participants, only serum sample will be collected for selenium assessment

Locations

Country Name City State
China Peking Union Medical College Hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking Union Medical College Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary between-group difference in serum selenium comparison of the mean serum selenium between the two groups up to 24 weeks
Secondary between-group difference in serum deiodinase activity comparison of the mean deiodinase activity between the two groups up to 24 weeks
Secondary between-group difference in erythrocyte glutathione peroxidase activity comparison of the mean erythrocyte glutathione peroxidase activity between the two groups up to 24 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03445078 - Correction of Selenium Deficiency Has Effect on Thyroid Function N/A
Recruiting NCT03421314 - Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment. N/A
Not yet recruiting NCT04683575 - Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma Phase 4
Completed NCT00428649 - Optimization of Selenoprotein P in Chinese Subjects N/A
Recruiting NCT03377218 - Potential Preventive Effect of Selenium on Iodine-induced Thyroid Autoimmunity During Pregnancy N/A
Completed NCT02619344 - Endothelial Dysfunction and Selenium Status in Children With Acute Systemic Inflammatory Response N/A
Completed NCT01394068 - Prospective, Non-randomized Observational Trial of Selenium in Cardiac Surgery N/A
Completed NCT04662242 - The Prognostic Impact of Selenium On Critical Surgical Patients Phase 4
Completed NCT02980094 - Milk Biofortification Promotes Health Benefits in Institutionalized Elderly N/A